Volume 4 Supplement 2
P-cadherin expression in feline mammary tissues
© Figueira et al; licensee BioMed Central Ltd. 2010
Published: 24 September 2010
Placental cadherin (P-cadherin) is a classical cadherin  expressed by myoepithelial cells of the human mammary gland [2, 3]. Changes to P-cadherin expression have been observed and implicated in human breast carcinogenesis [4–6]. Feline mammary tumours show similarities with the women tumours concerning many histological characteristics and clinical evolution, being proposed as good animal model to study mammary carcinogenesis .
To study P-cadherin expression in feline mammary gland an immunohistochemistry assay was performed in 61 samples of normal (n = 4), hyperplastic (n = 12), benign (n = 6) and malignant (n = 39) feline mammary tissues and the immunostaining assessment was based on the estimated percentage of luminal epithelial cells labeling (aberrant expression).
In normal mammary gland, mammary hyperplasia and benign tumours, P-cadherin immunolabelling was restricted to myoepithelial cells. Nevertheless, in malignant tumours there was an aberrant epithelial P-cadherin immunoexpression in 64,1% (n = 25) of the cases, with a membranar and/or cytoplasmic pattern of cellular distribution. Consequently, P-cadherin expression in feline mammary lesions was not exclusive of myoepithelial cells.
It was possible to observe a significant statistical correlation between P-cadherin expression intensity and feline mammary lesions (p = 0.0001). In malignant mammary tumors a statistical correlation between P-cadherin immunoexpression intensity and histological grade was observed (p = 0.0132). Aberrant epithelial P-cadherin expression seems to be correlated with tumor malignancy in feline mammary gland.
- Nollet F, Kools P, van Roy F: Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol. 2000, 299: 551-572. 10.1006/jmbi.2000.3777.View ArticlePubMedGoogle Scholar
- Cowin P, Rowlands TM, Hatsell SJ: Cadherins and catenins in breast cancer. Curr Opin Cell Biol. 2005, 17: 499-508. 10.1016/j.ceb.2005.08.014.View ArticlePubMedGoogle Scholar
- Paredes J, Correia AL, Ribeiro AS, Albergaria A, Milanezi F, Schmitt FC: P-cadherin expression in breast cancer: a review. Breast Cancer Res. 2007, 9: 214-10.1186/bcr1774.PubMed CentralView ArticlePubMedGoogle Scholar
- Gamallo C, Moreno-Bueno G, Sarrió D, Calero F, Hardisson D, Palacios J: The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Mod Pathol. 2001, 14: 650-654. 10.1038/modpathol.3880367.View ArticlePubMedGoogle Scholar
- Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F: P-cadherin expression is associated with high-grade ductal in situ of the breast. Virchows Arch. 2002, 440: 16-21. 10.1007/s004280100487.View ArticlePubMedGoogle Scholar
- Paredes J, Albergaria A, Oliveira JT, Jerónimo C, Milanezi F, Schmitt FC: P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation. Clin Cancer Res. 2005, 11: 5869-5877. 10.1158/1078-0432.CCR-05-0059.View ArticlePubMedGoogle Scholar
- Misdorp W, Weijer K: Animal Model of Human Disease. Breast Cancer. Am J Pathol. 1980, 98: 573-576.PubMed CentralPubMedGoogle Scholar
This article is published under license to BioMed Central Ltd.